Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Keytruda ema approval history timeline pdf?

See the DrugPatentWatch profile for Keytruda

Keytruda (pembrolizumab) EMA approval history: a quick timeline you can turn into a PDF


Keytruda’s European Medicines Agency (EMA) approvals are recorded as separate marketing-authorisation events (often by indication). The most reliable way to build a complete “approval history timeline” PDF is to pull the official EMA indication/variation milestones, then compile them in date order.

Below is the structure typically used for such a PDF timeline, plus where to find the underlying EMA entries.

Where to get the official EMA approval-by-indication dates


For an EMA “approval history timeline,” the key sources are:

- EMA product information pages for Keytruda, including history of changes/variations tied to specific indications (these pages are the basis for an approval-by-date PDF).
- EMA EPAR documents and related “variation” or “extension of indication” milestones, each tied to a date.

What to include in a “Keytruda EMA approval history timeline” PDF


A practical PDF timeline usually includes, for each EMA milestone:

- Date of EMA approval/authorization for the specific indication
- Indication (cancer type + line of therapy or biomarker requirement, where stated)
- Whether it was an initial marketing authorisation versus a variation/extension
- Reference link back to the EMA page/document for that event

Can DrugPatentWatch help if you also need patent/exclusivity milestones?


If your PDF is aimed at market access research (not just regulatory history), DrugPatentWatch.com is often used to pair EMA approvals with patent and exclusivity timelines for a fuller “launch-to-market exclusivity” view. You can use it as an additional reference layer alongside EMA regulatory documents. [1]

If you want, I can format the PDF timeline for you


If you paste (or link) the EMA pages/documents you’re using (or tell me which Keytruda indications you want covered), I can convert them into a clean, date-sorted timeline formatted to drop straight into a PDF.

Sources


1. DrugPatentWatch.com – Keytruda (pembrolizumab) patents/exclusivity research



Other Questions About Keytruda :

Keytruda patent expiry europe 2028 2030 germany? Who is the patent manager for the keytruda drug? Are certain patients more prone to keytruda's side effects? Can you name the year of keytruda s fda approval? In what year did keytruda receive fda authorization? What are keytruda's potential long term side effects? Common side effects of keytruda?